In both prostate and bladder cancer, TEV-associated TGF-β1 induces stromal fibroblasts to acquire a myofibroblast-like phenotype by activating the SMAD signaling pathway, thereby promoting tumor growth and angiogenesis in vivo (89, 90). The gene discussed is TGFB1; the disease is neoplasm.